Galangin targets HSP90β to alleviate ulcerative colitis by controlling fatty acid synthesis and subsequent NLRP3 inflammasome activation.
Ling YangXing-Yu MaKe-Xin MuYue DaiXia YufengZhi-Feng WeiPublished in: Molecular nutrition & food research (2023)
These results not only provide insight into the potential therapeutic use of Gal in the treatment of UC, but also offer new perspectives on the role of HSP90β in this disease. This article is protected by copyright. All rights reserved.